Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04763928
Status:
UNKNOWN
Last Update Posted:
2022-01-04
First Post:
2021-02-17
Brief Title:
Trial in AML Secondary to MPNs Patients Unfit for Intensive Chemotherapy Investigating a Treatment Combination Including Decitabine and Venetoclax
Sponsor:
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
101
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: